Clinical Trial Update: Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing cetuximab plus oxaliplatin and 5-FU/LV versus oxaliplatin and 5-FU/LV in previously treated EGFR-positive metastatic colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED